Deferred Registration - Quotient Sciences Code: QSC303945
This study is an early-stage Phase 1 trial run by Quotient Sciences. It is designed to test a new medicine for the first time or in early development, checking its safety and how it moves through the human body. The trial is currently recruiting healthy men between the ages of 30 and 65. You might notice that specific details about the medicine are not yet listed. This is known as a 'deferred registration'. In the UK, researchers can temporarily keep certain details confidential to protect new scientific discoveries. Full details will be made public once this period ends. Taking part in Phase 1 trials usually involves visiting a specialist clinic, undergoing health checks, taking the study medicine, and being monitored closely by a medical team. Healthy volunteers play a crucial role in developing future treatments.
At a glance
What is this study about?
Phase 1 clinical trials are the earliest stages of testing new medicines in humans. Before a treatment can be given to patients living with an illness, scientists must first make sure it is safe. To do this, they often invite healthy volunteers to take small doses under close medical supervision. This study, organised by Quotient Sciences, aims to understand how a new treatment behaves inside the human body.
On the trial registry, this study is listed with a 'deferred registration'. This simply means that full scientific details—such as the exact name of the drug and what condition it is being developed for—are temporarily kept private. This is a common and permitted practice in the UK to protect commercial research and new inventions. The full scientific details will be added to the public record as soon as the deferral period expires.
Even though the public summary is brief, the study must still follow strict UK safety regulations and ethics approvals before any volunteer takes part. By testing how the body absorbs, breaks down, and removes the medicine, researchers can work out safe doses for future studies. Studies like this are vital for turning scientific ideas into life-saving medicines.
Key takeaways
- This is an early Phase 1 safety trial run by Quotient Sciences.
- The study is currently open to healthy men aged between 30 and 65.
- Specific drug details are temporarily delayed from the public registry under standard UK research rules.
- Volunteers will receive full health checks and are closely monitored by doctors.
- Taking part is completely voluntary and participants can withdraw at any time.
Who may be eligible?
This study is looking for men aged between 30 and 65 years old who are in good general health. Because this is a Phase 1 safety trial, researchers need people who do not have major medical conditions, so they can clearly see how the new medicine affects the body on its own.
Although the full scientific criteria have not yet been published, volunteers for healthy trials are usually expected not to smoke heavily or take regular prescription medicines. You would also need to be willing to attend appointments and follow the study team's guidance.
If you are interested, the research clinic will carry out a thorough health screening before you join. This usually includes blood tests, heart checks, and a full medical history to make sure taking part is completely safe for you.
Could this study suit you?
Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.
- I am a man aged between 30 and 65 years old.
- I consider myself to be in good general health.
- I do not have major long-term illnesses or uncontrolled medical conditions.
- I am comfortable attending a clinical unit for health checks and possible overnight stays.
- I am willing to follow the study rules and trial schedule.
What does participation involve?
Taking part in a Phase 1 study usually involves an initial screening visit to check your general health, including blood tests, urine tests, and heart tracings (ECGs). If you are eligible, you will be invited to stay at or visit a specialist clinical unit. During the study, you will receive a dose of the study medicine and medical staff will regularly check your blood pressure, temperature, and blood samples to see how your body responds. After the treatment period, you will attend one or more follow-up visits so doctors can ensure you remain well. The exact number of visits, overnight stays, and overall study duration will be explained by the clinic team before you agree to join.
Potential risks and benefits
Locations (1)
- Quotient Sciences LimitedCity onlyNottingham, England
Common questions
What does 'deferred registration' mean?
It means the researchers have permission to delay publishing the full details of the study medicine on public registries to protect new inventions or business secrets. All standard safety and ethical approvals still apply.
Why are only men aged 30 to 65 eligible?
Early trials often focus on a specific, narrow group of people to keep the test results clear, consistent, and safe before testing the medicine in wider groups.
Do volunteers get paid for taking part?
Yes, Phase 1 studies with healthy volunteers almost always offer financial compensation for your time, effort, and any travel expenses.
Where does the study take place?
It is managed by Quotient Sciences, a clinical research company that operates specialist medical testing facilities in the UK.
Can I leave the study if I change my mind?
Yes. Joining a clinical trial is entirely voluntary. You can choose to stop and leave the study at any point without penalty.
How to find out more
Early Phase Clinical Team
Always speak to your GP or specialist before deciding to take part in a study.
Interested in taking part?
Discussion
Community discussion
Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.